Modulation of physical environment makes placental mesenchymal stromal cells suitable for therapy

Cell Biology International

Volumn 37, Issue 11, 2013, Pages 1197-1204

  Mathew, Suja Ann ^a   Rajendran, Sowmya ^a   Gupta, Pawan Kumar ^b   Bhonde, Ramesh ^a  

^a Manipal Academy of Higher Education   (India)

^b Akshay Tech Park   (India)

Author keywords

Hypoxia; Normoxia; Placenta; Proliferation; Stem cells; Viability

Indexed keywords

CELL MARKER;

ARTICLE; CELL ACTIVITY; CELL ASSAY; CELL GROWTH; CELL HYPOXIA; CELL METABOLISM; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CELL THERAPY; CELL VIABILITY; CELLULAR PARAMETERS; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; METABOLIC RATE; PHYSICAL PARAMETERS; PLACENTA; PROCEDURES CONCERNING CELLS; PROTEIN EXPRESSION;

HYPOXIA; NORMOXIA; PLACENTA; PROLIFERATION; STEM CELLS; VIABILITY;

CELL HYPOXIA; CELL MEMBRANE; CELL PROLIFERATION; CELL SEPARATION; CELL SHAPE; CELL SURVIVAL; CELLS, CULTURED; CELLULAR MICROENVIRONMENT; DACTINOMYCIN; FEMALE; FIBROBLASTS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; OXYGEN; PHENOTYPE; PLACENTA; PREGNANCY; TIME FACTORS;

EID: 84885861187     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10154     Document Type: Article

References (29)

1. Al-Khaldi A, Al-Sabti H, Galipeau J, Lachapelle K (2003) Therapeutic angiogenesis using autologous bone marrow stromal cells:improved blood flow in a chronic limb ischemia model. Ann Thorac Surg 75:204-9.
2. Balasubramanian S, Venugopal P, Sundarraj S, Zakaria Z, Majumdar AS, Ta M (2012) Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells. Cytotherapy 14(1): 26-33.
3. Barlow S, Brooke G, Chatterjee K, Price G, Pelekanos R, Rossetti T, Doody M, Venter D, Pain S, Gilshenan K, Atkinson K (2008) Comparison of human placenta-and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells Dev 17(6): 1095-07.
4. Borlongan CV, Glover LE, Tajiri N, Kaneko Y, Freeman TB (2011) The great migration of bone marrow-derived stem cells toward the ischemic brain:therapeutic implications for stroke and other neurological disorders. Prog Neurobiol 95(2):213-28.
5. Choi BY, Song JJ, Chang SO, Kim SU, Oh SH (2012) Intravenous administration of human mesenchymal stem cells after noiseor drug-induced hearing loss in rats. Acta Otolaryngol 132 (Suppl. 1):S94-102.
6. Dominici M, Le Blanc K,Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop DJ, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8(4):315-7.
7. Ezquer FE, Ezquer ME, Contador D, Ricca M, Simon V, Conget PA (2012) MSC anti-diabetic effect is unrelated to their transdifferentiation potential but to their capability to restore Th1/ Th2 balance and to modify the pancreatic microenvironment. Stem Cells 30(8):1664-74. doi:10.1002/stem.1132
8. Fryer BH, Simon MC (2006) Hypoxia, HIF and the placenta. Cell Cycle 5(5):495-8.
9. Heppenstall RB, Grislis G,Hunt TK (1975) Tissue gas tensions and oxygen consumption in healing bone defects. Clin Orthop Relat Res 106:357-65.
10. Hung SP, Ho JH, Shih YR, Lo T, Lee OK (2012) Hypoxia promotes proliferation and osteogenic differentiation potentials of human mesenchymal stem cells. J Orthop Res 30(2):260-6.
11. Huang YC, Yang ZM, Jiang NG, Chen XH, Li XQ, Tan MY, Zhou KP, Tang L, Xie HQ, Deng L (2010) Characterization of MSCs from human placental decidua basalis in hypoxia and serum deprivation. Cell Biol Int 34(3):237-43.
12. Iwase T, Nagaya N, Fujii T, Itoh T, Murakami S, Matsumoto T, Kangawa K, Kitamura S (2005) Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hind limb ischemia. Cardiovasc Res 66: 543-551.
13. In't Anker PS, Scherjon SA, Kleijburg-van derKeur C, de Groot-Swings GM, Claas FH, Fibbe WE, Kanhai HH (2004) Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22(7):1338-45.
14. Lee JM, Jung J, Lee HJ, Jeong SJ, Cho KJ, Hwang SG, KimGJ (2012) Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells. Int Immunopharmacol 13(2):219-24. doi:10.1016/j. intimp.2012.03.024 Epub.2012 Apr. 6.
15. Liu H, Liu S, Li Y,Wang X, XueW, Ge G, Luo X (2012) The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury. PLoS ONE 7(4):e34608.
16. Mathews S, Gupta PK, Bhonde R, Totey S (2011) Chitosan enhances mineralization during osteoblast differentiation of human bone marrow-derived mesenchymal stem cells, by up regulating the associated genes. Cell Prolif 44(6):537-49.
17. Moon MH, KimSY, Kim YJ, Kim SJ, Lee JB, Bae YC, Sung SM, Jung JS (2006)Human adipose tissue derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hind limb ischemia. Cell Physiol Biochem 17:279-90.
18. Nakagami H, Maeda K, Morishita R, Iguchi S, Nishikawa T, Takami Y, Kikuchi Y, Saito Y, Tamai K, Ogihara T, Kaneda Y (2005) Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissuederived stromal cells. Arterioscler Thromb Vasc Biol 25:2542-7.
19. NekantiU, Dastidar S, Venugopal P, Totey S, TaM(2010) Increased proliferation and analysis of differential gene expression in human Wharton's jelly-derived mesenchymal stromal cells under hypoxia. Int J Biol Sci 6:499-512.
20. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R,Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143-7.
21. Pittenger MF, Martin BJ (2004) Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95:9-20.
22. Rosenkranz K, Meier C (2011) Umbilical cord blood cell transplantation after brain ischemia -from recovery of function to cellular mechanisms. Ann Anat 193(4):371-9.
23. Rosová I, Dao M, Capoccia B, Link D, Nolta JA (2008) Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26(8):2173-82.
24. Rus Ciucǎ D, Sori{ogonek};ťau O, U{ogonek};sman S, Pop VI, Mihu CM (2011) Isolation and characterization of chorionic mesenchymal stem cells from the placenta. Rom J Morphol Embryol 52(3): 803-8.
25. Sahin AO, Buitenhuis M (2012) Molecular mechanisms underlying adhesion and migration of hematopoietic stem cells. Cell Adh Migr 6(1):39-48.
26. Toffoli S, Michiels C (2008) Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumors. FEBS J 275(12):2991-3002.
27. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD (2002) Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105: 93-8.
28. Wang JA, Chen TL, Jiang J, Shi H, Gui C, Luo RH, Xie XJ, Xiang MX, Zhang X (2008) Hypoxic preconditioning attenuates hypoxia/re-oxygenation-induced apoptosis in mesenchymal stem cells. Acta Pharmacol Sin 29(1):74-82.
29. Ziadloo A, Burks SR, Gold EM, Lewis BK, Chaudhry A, Merino MJ, Frenkel V, Frank JA (2012) Enhanced homing permeability and retention of bone marrow stromal cells by noninvasive pulsed focused ultrasound. Stem Cells 30(6): 1216-27.